No Data
No Data
Prelude Therapeutics (PRLD.US) once surged 28%! Reached clinical trial cooperation and supply agreement with Merck (MRK.US).
Recently, Prelude Therapeutics has reached a clinical trial cooperation and supply agreement with Merck.
Prelude, Merck Strike Clinical Trial Collaboration and Supply Pact
Express News | Prelude Therapeutics- Co, Merck Each Retain All Commercial Rights to Their Respective Compounds, Including as Monotherapy or as Combination Therapies
Express News | Prelude Therapeutics Inc - Expects to Conclude Monotherapy Dose Escalation Mid-2024 and Identify Recommended Phase 2 Dose
Express News | Prelude Therapeutics Inc - Prelude Will Sponsor Clinical Trial and Merck Will Provide Keytruda.
Express News | Prelude Therapeutics Announces Clinical Collaboration With Merck to Evaluate PRT3789 in Combination With Keytruda® (Pembrolizumab) in Patients With Smarca4-Mutated Cancers
No Data